Author

Sherif Elsamany

Institution: King Abdullah Medical City

Observed institutions: Mansoura University, Mansoura University Hospital, King Abdullah Medical City

ORCID: 0000-0001-5506-6494

Observed ORCID: 0000-0001-5506-6494

OpenAlex ID: A5038356801

Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study

2024 · Shouki Bazarbashi, Radwan Alkhatib, et al. · JCO Global Oncology · 13

A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).

2019 · Khalid Al-Saleh, Nashwa Abd El-Aziz, et al. · PubMed · 8

Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia

2022 · Mohammed Alghamdi, Shouki Bazarbashi, et al. · Journal of Oncology · 4

Optimizing second-line endocrine-based treatment in HR positive HER2 negative metastatic breast cancer: a comprehensive expert statement from the Gulf Cooperation Council Region

2026 · Ahmed Alshehri, Abdullah Khalaf Altwairgi, et al. · Frontiers in Oncology · 1

Works count: 4

Citation count: 26

H-index: 3

I10-index: 1